Serum brain-derived neurotrophic factor differences between the luteal and follicular phases in premenstrual dysphoric disorder

General Hospital Psychiatry

Volumn 37, Issue 3, 2015, Pages 266-272

  Oral, Elif ^a   Kirkan, Tulay Sati ^b   Yildirim, Abdulkadir ^a   Kotan, Zerrin ^a   Cansever, Zeliha ^a   Ozcan, Halil ^a   Aliyev, Elvin ^a   Gulec, Mustafa ^c  

^a ATATÜRK UNIVERSITY   (Turkey)

^b Erzurum Region Training and Research Hospital   (Turkey)

^c IZMIR KATIP CELEBI UNIVERSITY   (Turkey)

Author keywords

Brain derived neurotrophic factor; Follicular; Luteal; Premenstrual dysphoric disorder

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; ESTROGEN; PROGESTERONE; BRAIN-DERIVED NEUROTROPHIC FACTOR, HUMAN;

ADULT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DISEASE ASSOCIATION; ESTROGEN BLOOD LEVEL; FEMALE; FOLLICULAR PHASE; HUMAN; LUTEAL PHASE; NEUROMODULATION; PREMENSTRUAL DYSPHORIC DISORDER; PROGESTERONE BLOOD LEVEL; PROTEIN BLOOD LEVEL; BLOOD; YOUNG ADULT;

ADULT; BRAIN-DERIVED NEUROTROPHIC FACTOR; FEMALE; FOLLICULAR PHASE; HUMANS; LUTEAL PHASE; PREMENSTRUAL DYSPHORIC DISORDER; YOUNG ADULT;

EID: 84930181903     PISSN: 01638343     EISSN: 18737714     Source Type: Journal    
DOI: 10.1016/j.genhosppsych.2015.03.001     Document Type: Article

References (82)

1. Silva C.M., Gigante D.P., Carret M.L., Fassa A.G. Population study of premenstrual syndrome. Rev Saude Publica 2006, 40:47-56.
2. Teng C.T., Filho A.H., Artes R., Gorenstein C., Andrade L.H., Wang Y.P. Premenstrual dysphoric symptoms amongst Brazilian college students: factor structure and methodological appraisal. Eur Arch Psychiatry Clin Neurosci 2005, 255:51-56.
3. American Psychiatric Association (APA) Premenstrual dysphoric disorder. Diagnostic and statistical manual of mental disorders, fourth edition, text revision (DSM-IV-TR) 2000, 771-774. APA, Washington, DC. M.B. First (Ed.).
4. Rapkin A.J., Winer S.A. Premenstrual syndrome and premenstrual dysphoric disorder: Quality of life and burden of illness. Expert Rev Pharmacoecon Outcomes Res 2009, 9:157-170.
5. Zachar P., Kendler K.S. A diagnostic and statistical manual of mental disorders history of premenstrual dysphoric disorder. J Nerv Ment Dis 2014, 202:346-352.
6. Halbreich U. The diagnosis of premenstrual syndromes and premenstrual dysphoric disorder clinical procedures and research perspectives. Gynecol Endocrinol 2004, 19:320-334.
7. Derman O., Kanbur N.O., Tokur T.E., Kutluk T. Premenstrual syndrome and associated symptoms in adolescent girls. Eur J Obstet Gynecol Reprod Biol 2004, 116:201-206.
8. Braverman P.K. Premenstrual syndrome and premenstrual dysphoric disorder. J Pediatr Adolesc Gynecol 2007, 20:3-12.
9. Rapkin A.J., Mikacich J.A. Premenstrual syndrome and premenstrual dysphoric disorder in adolescents. Curr Opin Obstet Gynecol 2008, 20:455-463.
10. Inoue Y., Terao T., Iwata N., Okamoto K., Kojima H., Okamoto T., et al. Fluctuating serotonergic function in premenstrual dysphoric disorder and premenstrual syndrome: Findings from neuroendocrine challenge tests. Psychopharmacology (Berl) 2007, 190:213-219.
11. Batra N.A., Seres-Mailo J., Hanstock C., Seres P., Khudabux J., Bellavance F., et al. Proton magnetic resonance spectroscopy measurement of brain glutamate levels in premenstrual dysphoric disorder. Biol Psychiatry 2008, 63:1178-1184.
12. Cubeddu A., Bucci F., Giannini A., Russo M., Daino D., Russo N., et al. Brain-derived neurotrophic factor plasma variation during the different phases of the menstrual cycle in women with premenstrual syndrome. Psychoneuroendocrinology 2011, 36:523-553.
13. Dereboy Ç., Dereboy I.F., Yigitol F. Psychometric data for the Premenstrual Assessment Form: A cluster analytic study. Turk Psikiyatri Derg 1994, 5:83-90.
14. Steiner M., Dunn E.J. The psychobiology of female-specific mood disorders. Infertil Reprod Med Clin North Am 1996, 7:297-313.
15. Rapkin A.J., Morgan M., Goldman N., Brann D.W., Simone D., Mahesh V.B. Progesterone metabolite allopregnanolone in women with premenstrual syndrome. Obstet Gynecol 1997, 90:709-714.
16. Majewska M.D., Harrison R., Schwartz R.D., Barker J.L., Paul S.M. Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science 1986, 232:1004-1007.
17. Smith S.S., Gong Q.J., Hsu F.C., Markowitz R.S., French-Mullen J.M., Li X. GABA A receptor alpha4 subunit suppression prevents withdrawal properties of an endogenous steroid. Nature (London) 1998, 392:926-930.
18. Majewska M.D. Neurosteroids: endogenous bimodal modulators of the GAUA-A receptor. Mechanism of action and physiological significance. Prog Neurobiol 1992, 38:379-395.
19. Sousa A., Ticku M.K. Interaction of the neurosteroid DHEAS with the GABA-A receptor complex reveals that it may act via the pirotoxin site. J Pharmacol Exp Ther 1997, 282:827-833.
20. Barde Y.A., Edgar D., Thoenen H. Purification of a new neurotrophic factor from mammalian brain. EMBO J 1982, 1:549-553.
21. Bartkowska K., Turlejski K., Djavadian R.L. Neurotrophins and their receptors in early development of the mammalian nervous system. Acta Neurobiol Exp 2010, 70:454-467.
22. Dawbarn D., Allen S.J. Neurotrophins and neurodegeneration. Neuropathol Appl Neurobiol 2003, 29:211-230.
23. Alonso M., Vianna M.R., Depino A.M., Mello e Souza T., Pereira P., Szapiro G. BDNF-triggered events in the rat hippocampus are required for both short and long term memory formation. Hippocampus 2002, 12:551-560.
24. Berkinschtein P., Cammarota M., Igaz L.M., Bevilaqua L.R., Izquierdo I., Medina J.H. Persistence of long-term memory storage requires a late protein synthesis and BDNF dependent phase in the hippocampus. Neuron 2007, 53:261-277.
25. Caraci F., Copani A., FerdinandoNicoletti F., Drago F. Depression and Alzheimer's disease: neurobiological links and common pharmacological targets. Eur J Pharmacol 2010, 626:64-71.
26. Gosselin R.D., Suter M.R., Ji R.R., Decosterd I. Glial cells and chronic pain. Neuroscientist 2010, 16:519-531.
27. Grande I., Gabriel Rodrigo Fries G.R., Kunz M., Kapczinski F. The role of BDNF as a mediator of neuroplasticity in bipolar disorder. Psychiatry Investig 2010, 7:243-250.
28. Karege F., Perret G., Bondolfi G., Schwald M., Bertschy G., Aubry J.M. Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res 2002, 109:143-148.
29. Oliveira G.S., Ceresér K.M., Fernandes B.S., Kauer-Sant'Anna M., Fries G.R., Stertz L. Decreased brain-derived neurotrophic factor in medicated and drug-free bipolar patients. J Psychiatr Res 2009, 43:1171-1174.
30. Gazal M., Motta L.S., Wiener C.D., Fernandes J.C., Quevedo L.A., Jansen K., et al. Brain-derived neurotrophic factor in post-partum depressive mothers. Neurochem Res 2012, 37(3):583-587.
31. Minelli A., Zanardini R., Bonvicini C., Sartori R., Pedrini L., Gennarelli M., et al. BDNF serum levels, but not BDNF Val66Met genotype, are correlated with personality traits in healthy subjects. Eur Arch Psychiatry Clin Neurosci 2011, 261:323-329.
32. Lee H.Y., Kim Y.K. Plasma brain-derived neurotrophic factor as a peripheral marker for the action mechanism of antidepressants. Neuropsychobiology 2008, 57:194-199.
33. Tapia-Arancibia L., Rage F., Givalois L., Arancibia S. Physiology of BDNF: Focus on hypothalamic function. Rev Front Neuroendocrinol 2004, 25:77-107.
34. Begliuomini S., Casarosa E., Pluchino N., Lenzi E., Centofanti M., Freschi L., et al. Influence of endogenous and exogenous sex hormones on plasma brain-derived neurotrophic factor. Hum Reprod 2007, 22:995-1002.
35. Barbany G., Persson H. Regulation of Neurotrophin mRNA Expression in the rat brain by glucocorticoids. Eur J Neurosci 1992, 4:396-403.
36. Barbany G., Persson H. Adrenalectomy attenuates kainic acid-elicited increases of messenger RNAs for neurotrophins and their receptors in the rat brain. Neuroscience 1993, 54:909-922.
37. Bova R., Micheli M.R., Qualadrucci P., Zucconi G.G. BDNF and trkB mRNAs oscillate in rat brain during the light-dark cycle. Brain Res Mol Brain Res 1998, 57:321-324.
38. Schaaf M.J., de Jong J., de Kloet E.R., Vreugdenhil E. Downregulation of BDNF mRNA and protein in the rat hippocampus by corticosterone. Brain Res 1998, 813:112-120.
39. Yonkers K.A., O'Brien P.M.S., Eriksson E. Premenstrual syndrome. Lancet 2008, 71:1200-1210.
40. Singh M., Su C. Progesterone, brain-derived neurotrophic factor and neuroprotection. Neuroscience 2012, 10.1016/j.neuroscience.2012.09.056.
41. Su C., Cunningham R.L., Rybalchenko N., Singh M. Progesterone increases the release of brain-derived neurotrophic factor from glia via progesterone receptor membrane component 1 (pgrmc1)-dependent ERK5 signaling. Endocrinology 2012, 153:4389-4400.
42. Endicott J., Nee J., Harrison W. Daily Record of Severity of Problems (DRSP): Reliability and validity. Arch Womens Ment Health 2006, 9:41-49.
43. Duman R.S., Malberg J., Nakagawa S., D'Sa C. Neuronal plasticity and survival in mood disorders. Biol Psychiatry 2000, 48:732-739.
44. Oral E., Canpolat S., Yildirim S., Gulec M., Aliyev E., Aydin N. Cognitive functions and serum levels of brain-derived neurotrophic factor in patients with major depressive disorder. Brain Res Bull 2012, 88:454-459.
45. Gazal M., Motta L.S., Wiener C.D., Fernandes J.C., Quevedo L.A., Jansen K. Brain-derived neurotrophic factor in post-partum depressive mothers. Neurochem Res 2011, 37:583-587.
46. Siuciak J.A., Lewis D.R., Wiegand S.J., Lindsay R.M. Antidepressant- like effect of brain-derived neurotrophic factor (BDNF). Pharmacol Biochem Behav 1997, 56:131-137.
47. Stutzmann G.E., LeDoux J.E. GABAergic antagonists block the inhibitory effects of serotonin in the lateral amygdala: a mechanism for modulation of sensory inputs related to fear conditioning. J Neurosci 1999, 19:RC8.
48. Madhav T.R., Pei Q., Zetterstrom T.S. Serotonergic cells of the rat raphe nuclei express mRNA of tyrosine kinase B (trkB), the high-affinity receptor for brain derived neurotrophic factor (BDNF). Brain Res Mol Brain Res 2001, 93:56-63.
49. Chen B., Dowlatshahi D., MacQueen G.M., Wang J.F., Young L.T. Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biol Psychiatry 2001, 50:260-265.
50. Gonul A.S., Akdeniz F., Taneli F., Donat O., Eker C., Vahip S. Effect of treatment on serum brain-derived neurotrophic factor levels in depressed patients. Eur Arch Psychiatry Clin Neurosci 2005, 255:381-386.
51. Andréen L., Nyberg S., Turkmen S., van Wingen G., Fernández G., Bäckström T. Sex steroid induced negative mood may be explained by the paradoxical effect mediated by GABAA modulators. Psychoneuroendocrinology 2009, 34:1121-1232.
52. Fish E.W., Faccidomo S., DeBold J.F., Miczek K.A. Alcohol, allopregnanolone and aggression in mice. Psychopharmacology (Berl) 2001, 4:473-483.
53. Gulinello M., Gong Q.H., Li X., Smith S.S. Short-term exposure to a neuroactive steroid increases alpha4 GABA(A) receptor subunit levels in association with increased anxiety in the female rat. Brain Res 2001, 1:55-66.
54. Sundstrom I., Andersson A., Nyberg S., Ashbrook D., Purdy R.H., Backstrom T. Patients with premenstrual syndrome have a different sensitivity to a neuroactive steroid during the menstrual cycle compared to control subjects. Neuroendocrinology 1998, 2:126-138.
55. Miczek K.A., DeBold J.F., van Erp A.M., Tornatzky W. Alcohol, GABAA-benzodiazepine receptor complex, and aggression. Recent Dev Alcohol 1997, 13:139-171.
56. Timby E., Balgård M., Nyberg S., Spigset O., Andersson A., Porankiewicz-Asplund J., et al. Pharmacokinetic and behavioral effects of allopregnanolone in healthy women. Psychopharmacology (Berl) 2006, 186:414-424.
57. Gourley S.L., Debold J.F., Yin W., Cook J., Miczek K.A. Benzodiazepines and heightened aggressive behavior in rats: reduction by GABA(A)/alpha(1) receptor antagonists. Psychopharmacology (Berl) 2005, 178:232-240.
58. Whitnall M.H. Regulation of the hypothalamic corticotropin releasing hormone neurosecretory system. Prog Neurobiol 1993, 40:573-629.
59. Herbert J., Goodyer I.M., Grossman A.B., Hastings M.H., de Kloet E.R., Lightman S.L., et al. Do corticosteroids damage the brain?. J Neuroendocrinol 2006, 18:393-411.
60. Roca C.A., Schmidt P.J., Altemus M., Deuster P., Danaceau M.A., Putnam K., et al. Differential menstrual cycle regulation of hypothalamic-pituitary-adrenal axis in women with premenstrual syndrome and controls. J Clin Endocrinol Metab 2003, 88:3057-3063.
61. Lee E.E., Nieman L.K., Martinez P.E., Harsh V.L., Rubinow D.R., Schmidt P.J. ACTH and cortisol response to Dex/CRH testing in women with and without premenstrual dysphoria during GnRH agonist-induced hypogonadism and ovarian steroid replacement. J Clin Endocrinol Metab 2012, 97:1887-1896.
62. Meyer M., Gonzalez Deniselle M.C., Gargiulo-Monachelli G., Lima A., Roig P., Guennoun R., et al. Progesterone attenuates several hippocampal abnormalities of the wobbler mouse. J Neuroendocrinol 2012.
63. Su T.P., Schmidt P.J., Danaceau M., Murphy D.L., Rubinow D.R. Effect of menstrual cycle phase on neuroendocrine and behavioral responses to the serotonin agonist m-chlorophenylpiperazine in women with premenstrual syndrome and controls. J Clin Endocrinol Metab 1997, 82:1220-1228.
64. Girdler S.S., Straneva P.A., Light K.C., Pedersen C.A., Morrow A.L. Allopregnanolone levels and reactivity to mental stress in premenstrual dysphoric disorder. Biol Psychiatry 2001, 49:788-797.
65. Oral E., Ozcan H., Kirkan T.S., Askin S., Gulec M., Aydin N. Luteal serum BDNF and HSP70 levels in women with premenstrual dysphoric disorder. Eur Arch Psychiatry Clin Neurosci 2013, 263:685-693.
66. Endicott J., Amsterdam J., Eriksson E., Frank E., Freeman E., Hirschfeld R., et al. Is premenstrual dysphoric disorder a distinct clinical entity?. J Womens Health Gend Based Med 1999, 8:663-679.
67. Landén M., Eriksson E. How does premenstrual dysphoric disorder relate to depression and anxiety disorders?. Depress Anxiety 2003, 17:122-129.
68. Klatzkin R.R., Lindgren M.E., Forneris C.A., Girdler S.S. Histories of major depression and premenstrual dysphoric disorder: Evidence for phenotypic differences. Biol Psychol 2010, 84:235-247.
69. Bhatnagar S., Dallman M. Neuroanatomical basis for facilitation of hypothalamic- pituitary-adrenal responses to a novel stressor after chronic stress. Neuroscience 1998, 84:1025-1039.
70. Bhatnagar S., Vining C. Facilitation of hypothalamic-pituitary-adrenal responses to novel stress following repeated social stress using the resident/intruder paradigm. Horm Behav 2003, 43:158-165.
71. Jaferi A., Nowak N., Bhatnagar S. Negative feedback functions in chronically stressed rats: role of the posterior paraventricular thalamus. Physiol Behav 2003, 78:365-373.
72. McEwen B.S. Protective and damaging effects of stress mediators. N Engl J Med 1998, 338:171-179.
73. McEwen B.S. Glucocorticoids, depression and mood disorders: structural remodeling in the brain. Metabolism 2005, 54:20-23.
74. Vyas A., Mitra R., Rao B.S., Chattarji S. Chronic stress induces contrasting patterns of dendritic remodeling in hippocampal and amygdaloid neurons. J Neurosci 2002, 22:6810-6818.
75. Naert G., Ixart G., Maurice T., Tapia-Arancibia L., Givalois L. Brain-derived neurotrophic factor and hypothalamic-pituitary-adrenal axis adaptation processes in a depressive-like state induced by chronic restraint stress. Mol Cell Neurosci 2011, 46:55-66.
76. Schulte-Herbrüggen O., Chourbaji S., Ridder S., Brandwein C., Gass P., Hörtnagl H., et al. Stress-resistant mice overexpressing glucocorticoid receptors display enhanced BDNF in the amygdala and hippocampus with unchanged NGF and serotonergic function. Psychoneuroendocrinology 2007, 31:1266-1277.
77. Daftary S.S., Calderon G., Rios M. Essential role of brain-derived neurotrophic factor in the regulation of serotonin transmission in the basolateral amygdala. Neuroscience 2012, 224:125-134.
78. Krizsan-Agbas D., Pedchenko T., Hasan W., Smith P.G. Oestrogen regulates sympathetic neurite outgrowth by modulating brain derived neurotrophic factor synthesis and release by the rodent uterus. Eur J Neurosci 2003, 18:2760-2768.
79. Pluchino N., Cubeddu A., Begliuomini S., Merlini S., Giannini A., Bucci F., et al. Daily variation of brain-derived neurotrophic factor and cortisol in women with normal menstrual cycles, undergoing oral contraception and in postmenopause. Hum Reprod 2009, 24:2303-2309.
80. Scharfman H.E., MacLusky N.J. Estrogen and brain-derived neurotrophic factor (BDNF) in hippocampus: complexity of steroid hormone-growth factor interactions in the adult CNS. Front Neuroendocrinol 2006, 27:415-435.
81. Nakahashi T., Fujimura H., Altar C.A., Li J., Kambayashi J., Tandon N.N., et al. Vascular endothelial cells synthesize and secrete brain-derived neurotrophic factor. FEBS Lett 2000, 470:113-117.
82. Moalem G., Gdalyahu A., Shani Y., Otten U., Lazarovici P., Cohen I.R., et al. Production of neurotrophins by activated T cells: implications for neuroprotective autoimmunity. J Autoimmun 2000, 15:331-345.